Viridian Therapeutics, Inc. (LON: 0K1R)

Viridian Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 23, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,180	899	976	317	47	12
Market Cap Growth	136.09%	-7.85%	207.65%	573.54%	308.81%	-84.29%
Enterprise Value	741	777	741	280	32	-7
Last Close Price	15.23	16.90	24.32	16.17	20.30	38.05
PS Ratio	5752.02	3647.53	663.46	144.94	61.23	3.42
PB Ratio	2.46	2.59	2.98	2.29	0.54	0.97
P/TBV Ratio	3.35	4.86	4.65	7.97	-	0.97
EV/Sales Ratio	4596.22	3150.76	503.65	127.79	41.48	-
Debt / Equity Ratio	0.03	0.05	0.01	0.00	0.00	0.53
Asset Turnover	0.00	0.00	0.01	0.02	0.01	0.09
Quick Ratio	18.21	17.93	12.73	14.48	11.96	2.67
Current Ratio	18.55	18.26	12.93	14.68	12.14	2.92
Return on Equity (ROE)	-51.88%	-56.80%	-44.57%	-51.61%	-163.07%	-124.81%
Return on Assets (ROA)	-32.14%	-34.37%	-26.28%	-29.75%	-31.36%	-51.84%
Return on Capital (ROIC)	-34.14%	-36.80%	-28.52%	-32.28%	-35.04%	-58.31%
Earnings Yield	-16.25%	-20.76%	-11.05%	-18.49%	-172.21%	-274.49%
FCF Yield	-12.48%	-16.16%	-8.05%	-12.79%	-46.39%	-236.90%
Buyback Yield / Dilution	-42.07%	-39.48%	-169.22%	-235.07%	-70.27%	-5.87%
Total Shareholder Return	-42.07%	-39.48%	-169.22%	-235.07%	-70.27%	-5.87%

Source: S&P Capital IQ. Standard template. Financial Sources.